O'Malley Schotthoefer Erin, Yanovitch Tammy L, Freedman Sharon F
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, USA.
J AAPOS. 2008 Feb;12(1):33-9. doi: 10.1016/j.jaapos.2007.07.002. Epub 2007 Oct 17.
To determine the long-term outcomes and complications of aqueous drainage device surgery in children with congenital and aphakic glaucoma.
Chart review of consecutive children treated with aqueous drainage device surgery at Duke University Eye Center from 1995 to 2006, recording demographic, glaucoma-related, and anterior segment examination findings.
Included are 30 children (38 eyes) with congenital glaucoma and 32 children (41 eyes) with aphakic glaucoma. Median follow-up was 5.5 years (0.5-10.5) in the congenital glaucoma group and 3.5 years (0.5-13.8) in the aphakic glaucoma group. Pre-aqueous drainage device median intraocular pressure (IOP) was 29 mmHg in the congenital glaucoma group and 36 mmHg in the aphakic glaucoma group. Post-aqueous drainage device median IOP was 14 and 15 mmHg in the congenital and aphakic glaucoma group, respectively (p < 0.0001 vs pre-aqueous drainage device IOP). Post-aqueous drainage device pupil abnormalities were noted in 16% and 7% of eyes in the congenital glaucoma and aphakic glaucoma groups, respectively, and cataract occurred in 20% of phakic eyes in the congenital glaucoma group. Reoperation was necessary in 26% and 22% of eyes in the congenital glaucoma and aphakic glaucoma groups, respectively. One-year Kaplan-Meier success was 92% and 90% in the congenital and aphakic glaucoma groups, respectively, but fell by 10 years to 42% and 55%, respectively. Vision-threatening complications occurred in 10% of eyes overall.
Aqueous drainage device surgery is moderately successful in children with refractory congenital and aphakic glaucoma. Common complications include corneal touch and cataract; iris abnormalities occur less commonly.
确定先天性和无晶状体性青光眼患儿行房水引流装置手术的长期疗效和并发症。
回顾性分析1995年至2006年在杜克大学眼科中心接受房水引流装置手术的连续患儿病历,记录人口统计学、青光眼相关及眼前节检查结果。
纳入30例(38眼)先天性青光眼患儿和32例(41眼)无晶状体性青光眼患儿。先天性青光眼组中位随访时间为5.5年(0.5 - 10.5年),无晶状体性青光眼组为3.5年(0.5 - 13.8年)。先天性青光眼组房水引流装置植入术前中位眼压为29 mmHg,无晶状体性青光眼组为36 mmHg。先天性和无晶状体性青光眼组房水引流装置植入术后中位眼压分别为14 mmHg和15 mmHg(与房水引流装置植入术前眼压相比,p < 0.0001)。先天性青光眼组和无晶状体性青光眼组分别有16%和7%的患眼出现房水引流装置植入术后瞳孔异常,先天性青光眼组有20%的有晶状体患眼发生白内障。先天性青光眼组和无晶状体性青光眼组分别有26%和22%的患眼需要再次手术。先天性和无晶状体性青光眼组1年的Kaplan-Meier成功率分别为92%和90%,但到10年时分别降至42%和55%。总体上10%的患眼出现了威胁视力的并发症。
房水引流装置手术对于难治性先天性和无晶状体性青光眼患儿有一定成功率。常见并发症包括角膜接触和白内障;虹膜异常较少见。